today announced the appointment of Moncef Slaoui, Ph.D., as Chair Designate. Dr. Slaoui has been serving on the Company’s Board of Directors since June 2024. TOKYO, January 31, 2025--Meiji Seika ...

SAN DIEGO - Arcturus Therapeutics (NASDAQ:ARCT) Holdings Inc. (NASDAQ: ARCT), a company specializing in mRNA medicines for infectious diseases and rare disorders, has appointed Dr. Moncef Slaoui as ...

GlaxoSmithKline has fired its former research boss Moncef Slaoui from the board of Galvani Bioelectronics, a company it majority owns, after an internal investigation found he sexually harassed a ...

Bonus Apr 08, 1994 May 03, 1994 Mar 24, 1994 Bonus Ratio: 2 share(s) for every 1 shares held Bonus Dec 04, 1992 Dec 22, 1992 Sep 30, 1992 Bonus Ratio: 1 share(s) for every 1 shares held Dr. Reddy's ...

As bluebird bio struggles to get its gene therapies over the finishing line, the company says its financial position raises "substantial doubt" about its ability to continue as a going concern.